Contraception News and Research

Latest Contraception News and Research

Demand for long-acting reversible contraception seems to be on rise

Not long after Donald Trump was elected president, descriptive reports began rolling in: Demand for long-acting, reversible contraception such as intrauterine devices and implants seemed to be on the rise.

4 Feb 2019

The connection between the Pope and contraceptive pills

Millions of women around the world use the combined hormonal oral contraceptive pill whcih has been around the past six decades. The usual method advised is a 21 day cycle of the pill followed by a 7 day break when the woman bleeds.

22 Jan 2019

Podcast: KHN’s ‘What the Health?’ Drug prices are rising again. Is someone going to do something about it?

Many drugmakers have announced price increases with the start of the new year. The new Congress wants to do something about that. And even though both Republicans and Democrats want to address the politically potent issue of drug prices, it is unclear what they might be able to agree on.

17 Jan 2019

Contraceptive patch that could provide 6 months of contraception within seconds

Most birth control methods involving hormones involve daily intake of pills. Long acting contraceptive methods that involve implants or intrauterine devices (IUDs) need regular visits to the doctor and are not as acceptable to many women.

15 Jan 2019

New skin patch provides long-acting contraceptive protection

Researchers have developed a new skin patch that uses microneedle technology to deliver a long-acting contraceptive hormone.

14 Jan 2019

Research: Myths about migration and health not supported by available evidence

Research published in The Lancet on 5 December revealed that harmful and unfounded myths about migration and health have become accepted and that these are used to justify policies of exclusion.

13 Dec 2018

New book encompasses the vast history of reproduction

A new book is the first to encompass the vast history of how living things procreate, from the banks of the ancient Nile to the fertility clinics of today.

7 Dec 2018

Low-income women in Texas are not receiving contraception after childbirth, study shows

Low-income women in Texas who have delivered a baby are not getting the contraception they want at their six-week postpartum visit, a new study from the Texas Policy Evaluation Project shows.

5 Dec 2018

Abused women more likely to seek emergency contraception, study finds

Women who experience domestic violence and abuse are more than twice as likely to seek emergency contraception as other women, according to a study by National Institute for Health Research-funded researchers at the University of Bristol and Queen Mary University of London, suggesting that requests for emergency contraception could be an important sign of abuse.

4 Dec 2018

Women’s intentions and attitude matter when it comes to using contraception

A new Veterans Affairs study adds to the evidence that women's intentions around becoming pregnant don't fully explain whether and how they use contraception. Rather, their attitudes toward becoming pregnant also play a role.

30 Nov 2018

Gel formulation of a new male contraceptive on trial

The National Institutes of Health (NIH) is funding a clinical trial to see the safety and effectiveness of a new male contraceptive that would be available in gel formulation.

29 Nov 2018

FDA approves new treatment for AML patients

The U.S. Food and Drug Administration today approved Daurismo (glasdegib) tablets to be used in combination with low-dose cytarabine (LDAC), a type of chemotherapy, for the treatment of newly-diagnosed acute myeloid leukemia (AML) in adults who are 75 years of age or older or who have other chronic health conditions or diseases (comorbidities) that may preclude the use of intensive chemotherapy.

22 Nov 2018

Nexus announces availability of Arsenic Trioxide Injection in the US

Nexus Pharmaceuticals announced today the immediate availability in the United States for Arsenic Trioxide Injection. Nexus Pharmaceuticals' Arsenic Trioxide Injection is available as 10 mg per 10 mL vial for injection.

16 Nov 2018

Both parents and children agree about confidential medical services

When it comes to preventive care and confidential medical services, parents and their adolescent children actually agree with each other. They both believe that preventive care is important, that adolescents should be provided with opportunities to speak with their doctor one-on-one, and that some services should be confidential.

15 Nov 2018

Infant girls fed soy formula more likely to develop severe menstrual pain as adults, suggests research

New research suggests that infant girls fed soy formula are more likely to develop severe menstrual pain as young adults. The finding adds to the growing body of literature that suggests exposure to soy formula during early life may have detrimental effects on the reproductive system. The study appears online in the journal Human Reproduction.

9 Nov 2018

Vulnerable young teenagers urgently need better sex education, say researchers

Sexually active teenagers who were offered rapid, confidential chlamydia testing and same-day treatment at college mostly did not take up the offer, largely due to ignorance about the risks.

9 Nov 2018

UTSA research could help address genetically based challenges with male fertility

Millions of couples who have trouble conceiving may get relief from new research led by scientists at The University of Texas at San Antonio.

7 Nov 2018

FDA approves LORBRENA for treatment of patients with ALK-positive metastatic NSCLC

Pfizer Inc. today announced that the U.S. Food and Drug Administration has approved LORBRENA, a third-generation anaplastic lymphoma kinase tyrosine kinase inhibitor for patients with ALK-positive metastatic non-small cell lung cancer whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease; or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

5 Nov 2018

Study finds increased risks to mother and baby when pregnancies are closely spaced

Twelve to 18 months seems to be the ideal length of time between giving birth and getting pregnant again, according to new research from the University of British Columbia and the Harvard T.H. Chan School of Public Health.

29 Oct 2018

Novel test measures male fertility

At a time when more than half of male infertility cannot be explained by current methods, a new test developed by Androvia LifeSciences is able to measure male fertility.

25 Oct 2018